Neutra Corp. (NTRR) Stock Price & Analysis

Neutra Corp. (NTRR) rose 0.00% to USD 0 as of September 8, 2026 at 10:16 UTC, according to Nexqual real-time market data.

NTRR last closed at USD 0; the session ranged USD 0–0 on volume of 100,000 shares. Market capitalization is —, with a 52-week range of USD 0–0 (OID). Source: Nexqual, September 8, 2026 at 10:16 UTC.

Key Statistics (as of September 8, 2026 at 10:16 UTC)

Technical Analysis (NTRR)

Nexqual's technical model rates NTRR "SELL" based on 1 bullish and 4 bearish signals across 129 daily candles, as of September 8, 2026 at 10:16 UTC.

From Neutra Corp.'s Latest SEC 10-K Filing (filed 2024-08-02)

Key Strengths & Strategy (as disclosed to the SEC)

• However:   - 5 - Table of Contents   (a)  FDA:  The US Food and Drug Administration ("FDA") has stated that although hemp is no longer an illegal substance under the Farm Bill, the FDA continues to regulate cannabis products under the Food, Drug, and Cosmetic Act ("FD&C Act") and Section 351 of the Public Health Service Act.
• We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand.

Partnerships

• From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market.   On January 23, 2018, we entered into an agreement with Artillery Labs to sell and market natural nutraceuticals online.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:16 UTC. This page is informational and not investment advice.